Circuit Event and Unfilled Demand
The stock of Venus Remedies Ltd reached its upper circuit price limit of Rs 1710.6, representing a 5.0% gain within the 5% price band allowed for the day. This ceiling effectively froze trading at the peak price, signalling that demand exceeded what the price band could accommodate. The narrow intraday range of just Rs 1.8 between Rs 1706.4 and Rs 1708.2 further emphasises the tight trading near the circuit price, with buyers unable to push the price higher due to regulatory limits. Such unfilled demand is a hallmark of upper circuit events, especially in stocks with thinner liquidity profiles.
Delivery and Volume Analysis
Volume on the circuit day was 0.26212 lakh shares, translating to a turnover of approximately Rs 4.39 crore. While total traded volume is mechanically suppressed on circuit days due to the price lock, the delivery volume provides a clearer picture of buying conviction. On 28 Sep 2026, delivery volume rose by 31.31% to 24,730 shares compared to the 5-day average, indicating that a significant portion of traded shares were taken into long-term holdings rather than being flipped intraday. This rise in delivery volume during an upper circuit is a strong signal of genuine investor interest rather than speculative momentum — is this delivery surge a sign of sustained buying or a short-term spike?
Moving Averages and Trend Context
Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages — confirming a bullish trend. Clearing these technical levels prior to the circuit day suggests that the upper circuit was not an isolated spike but rather an amplification of an existing upward momentum. The weighted average price on the day was closer to the low price, indicating that most volume traded near the lower end of the intraday range before the price locked at the upper circuit. This pattern often reflects cautious accumulation before a breakout — does the moving average alignment support a sustainable rally or is it vulnerable to a pullback?
Liquidity and Market Capitalisation Profile
With a market capitalisation of Rs 2,219 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of Rs 0.12 crore based on 2% of the 5-day average traded value. While this level of liquidity is sufficient for retail and small institutional trades, it remains limited compared to larger caps. The micro-cap status means that upper circuit moves carry additional weight, as thin order books can exaggerate price moves and make entering or exiting sizeable positions challenging. This liquidity risk is an important consideration for investors — how does the liquidity constraint affect the risk-reward profile of this circuit move?
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Intraday Price Action
The intraday price action on 29 Sep 2026 was characterised by a narrow trading band of Rs 1.8, with the stock opening at Rs 1629.8 and touching a high of Rs 1706.4 before settling at the circuit price of Rs 1710.6. The opening gap up of 4.63% set the tone for the session, and the stock outperformed its sector by 4.36% while the Sensex declined by 0.25%. The narrow range near the upper circuit price is typical of such sessions, where the price is capped by regulatory limits but demand remains strong. The weighted average price being closer to the low price suggests that most volume was absorbed before the price locked, indicating a gradual build-up rather than a sudden spike.
Fundamental Context
Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space known for its growth potential and volatility. While the micro-cap status implies a smaller scale relative to industry giants, the company’s recent price action reflects heightened market attention. The sector’s 1-day return of 0.47% contrasts with the stock’s 4.90% gain, underscoring its outperformance on the day. However, fundamentals should be weighed alongside technical and liquidity factors to fully understand the move’s quality.
Holding Venus Remedies Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: What the Circuit and Data Signal
The upper circuit hit by Venus Remedies Ltd on 29 Sep 2026 reflects a scenario where buying demand outstripped supply within the 5% price band, resulting in a price freeze at Rs 1710.6. The rise in delivery volumes by over 31% against the recent average suggests that the move was supported by genuine accumulation rather than mere speculative trading. Coupled with the stock trading above all major moving averages, the technical backdrop confirms a bullish trend that the circuit amplified. However, the micro-cap status and limited liquidity, with a trade size capacity of just Rs 0.12 crore, introduce a notable liquidity risk. This constraint can make it difficult for investors to enter or exit positions without impacting the price, a factor that must be carefully considered — after a 5.0% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?
Key Data at a Glance
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
